US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

First Tracks Biotherapeutics Inc

37.98

-1.5900-4.02%

Post-market: 37.980.00000.00%19:30 EDT

Volume:389.08K

Turnover:14.92M

Market Cap:1.36B

PE:-8.38

High:40.69

Open:39.35

Low:37.40

Close:39.57

52wk High:49.91

52wk Low:14.72

Shares:35.73M

Float Shares:34.75M

Volume Ratio:0.55

T/O Rate:1.12%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.5296

ROE:-48.91%

ROA:-28.97%

PB:8.04

PE(LYR):- -

Loading ...

Overview Company News Filings

Piper Sandler Initiates Coverage on First Tracks Biotherapeutics With Overweight Rating, $54 Price Target

MT Newswires Live

First Tracks Initiated at Overweight by Piper Sandler

First Tracks Biotherapeutics initiated with an Overweight at Piper Sandler

Analysts Are Bullish on Top Healthcare Stocks: Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD), First Tracks Biotherapeutics Inc (TRAX)

HC Wainwright Initiates First Tracks Biotherapeutics at Buy

MT Newswires Live

First Tracks Initiated at Buy by HC Wainwright & Co.

First Tracks Biotherapeutics, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating and Target Price $30

THOMSON REUTERS

Weekly Update (WDC, IDT, TRAX)

First Tracks Initiated at Outperform by Leerink Partners

First Tracks Biotherapeutics initiated with an Outperform at Leerink

Leerink Partners Initiates Coverage on First Tracks Biotherapeutics With Outperform Rating

MT Newswires Live

First Tracks Biotherapeutics Inc : Wedbush Assumes Coverage With Outperform Rating; Target Price $30

THOMSON REUTERS

First Tracks Biotherapeutics Inc : Leerink Partners Initiates Coverage With Outperform Rating; Target Price $46

THOMSON REUTERS

First Tracks Biotherapeutics CFO Ajim Tamboli files initial beneficial ownership statement

First Tracks Biotherapeutics initial beneficial ownership filing shows EcoR1 Capital stake

Barclays Initiates First Tracks Biotherapeutics at Overweight

MT Newswires Live

First Tracks Biotherapeutics : Barclays Initiates Coverage With Overweight Rating and Target Price $40

THOMSON REUTERS

First Tracks Initiated at Buy by UBS

UBS Initiates Coverage on First Tracks Biotherapeutics With Buy Rating, $45 Price Target

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/TRAX/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TRAX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRAX\",,,,,undefined,":{"symbol":"TRAX","market":"US","secType":"STK","nameCN":"First Tracks Biotherapeutics Inc","latestPrice":37.98,"timestamp":1789070400000,"preClose":39.57,"halted":0,"volume":389076,"hourTrading":{"tag":"盘后","latestPrice":37.98,"preClose":37.98,"latestTime":"19:30 EDT","volume":4921,"amount":186895.66,"timestamp":1789083006188,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.04018195602729349,"floatShares":34748800,"shares":35730843,"eps":-4.529554,"marketStatus":"Not Yet Opened","change":-1.59,"latestTime":"09-10 16:00:00 EDT","open":39.35,"high":40.6916,"low":37.4,"amount":14915185.661640001,"amplitude":0.083184,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.529554,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789113600000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":39.57,"preHourTrading":{"tag":"盘前","latestPrice":41,"preClose":39.57,"latestTime":"07:14 EDT","volume":105,"amount":4169.800215,"timestamp":1789038877635,"change":1.43,"changeRate":0.036138,"amplitude":0.032853},"postHourTrading":{"tag":"盘后","latestPrice":37.98,"preClose":37.98,"latestTime":"19:30 EDT","volume":4921,"amount":186895.66,"timestamp":1789083006188,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.546772,"impliedVol":1.1632,"impliedVolPercentile":0.9765},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRAX\",,,,,undefined,":{"symbol":"TRAX","floatShares":34748800,"roa":"-28.97%","roe":"-48.91%","lyrEps":0,"volumeRatio":0.546772,"shares":35730843,"dividePrice":0,"high":40.6916,"amplitude":0.083184,"preClose":39.57,"low":37.4,"week52Low":14.72,"pbRate":"8.04","week52High":49.9114,"institutionHeld":0,"latestPrice":37.98,"eps":-4.529554,"divideRate":0,"volume":389076,"delay":0,"ttmEps":-4.529554,"open":39.35,"prevYearClose":20,"prevWeekClose":40.46,"prevMonthClose":41.84,"prevQuarterClose":20.12,"fiveDayClose":45.28,"twentyDayClose":46.13,"sixtyDayClose":17.88},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TRAX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"TRAX","fiscalQuarterEnding":"2026/06","expectedEps":-0.74,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-0.95}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TRAX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TRAX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1787112000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TRAX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TRAX","date":"2026-09-09","current":-8.384931,"percent":0.258065,"low":-10.141689,"twenty":-9.393656,"median":-4.289122,"eighty":-3.52395,"high":-3.156022,"avg":-6.082288,"sd":2.693739,"marketCap":1493549237},"quantilePoints":[{"date":"2026-04-24","current":-3.975194,"twenty":-3.975194,"median":-3.975194,"eighty":-3.975194,"marketCap":660227979},{"date":"2026-05-01","current":-4.868566,"twenty":-4.868566,"median":-4.085034,"eighty":-3.799448,"marketCap":808605530},{"date":"2026-05-08","current":-3.728313,"twenty":-4.68236,"median":-4.236719,"eighty":-3.799448,"marketCap":619224346},{"date":"2026-05-15","current":-3.799448,"twenty":-4.433387,"median":-4.031683,"eighty":-3.799448,"marketCap":631038952},{"date":"2026-05-22","current":-3.452672,"twenty":-4.299486,"median":-3.855938,"eighty":-3.664859,"marketCap":584796305},{"date":"2026-05-29","current":-3.259026,"twenty":-4.249272,"median":-3.799448,"eighty":-3.475745,"marketCap":551997467},{"date":"2026-06-05","current":-3.749322,"twenty":-4.203244,"median":-3.738817,"eighty":-3.411676,"marketCap":635041334},{"date":"2026-06-12","current":-3.508294,"twenty":-4.109513,"median":-3.726221,"eighty":-3.329068,"marketCap":594217248},{"date":"2026-06-18","current":-3.743141,"twenty":-4.020386,"median":-3.683399,"eighty":-3.361617,"marketCap":633994562},{"date":"2026-06-26","current":-3.372329,"twenty":-3.945066,"median":-3.663829,"eighty":-3.37851,"marketCap":571188276},{"date":"2026-07-02","current":-3.829664,"twenty":-3.955109,"median":-3.663829,"eighty":-3.376449,"marketCap":648649362},{"date":"2026-07-10","current":-6.674616,"twenty":-4.112294,"median":-3.726221,"eighty":-3.397462,"marketCap":1130513144},{"date":"2026-07-17","current":-7.459502,"twenty":-4.261943,"median":-3.735727,"eighty":-3.424655,"marketCap":1263453116},{"date":"2026-07-24","current":-7.754091,"twenty":-4.794084,"median":-3.774042,"eighty":-3.434543,"marketCap":1313349220},{"date":"2026-07-31","current":-9.842999,"twenty":-6.999282,"median":-3.799448,"eighty":-3.441135,"marketCap":1667157964},{"date":"2026-08-07","current":-9.334163,"twenty":-7.464446,"median":-3.842801,"eighty":-3.45844,"marketCap":1580973783},{"date":"2026-08-14","current":-9.814035,"twenty":-7.742967,"median":-3.975194,"eighty":-3.486045,"marketCap":1573229017},{"date":"2026-08-21","current":-9.33927,"twenty":-8.651869,"median":-4.081492,"eighty":-3.504998,"marketCap":1497122321},{"date":"2026-08-28","current":-9.97229,"twenty":-9.339073,"median":-4.144854,"eighty":-3.509324,"marketCap":1598597915},{"date":"2026-09-04","current":-9.475235,"twenty":-9.448042,"median":-4.257739,"eighty":-3.516946,"marketCap":1518918135},{"date":"2026-09-09","current":-9.31698,"twenty":-9.393656,"median":-4.289122,"eighty":-3.52395,"marketCap":1493549237}],"updateTime":1789108924873},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TRAX\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2632953840","title":"Piper Sandler Initiates Coverage on First Tracks Biotherapeutics With Overweight Rating, $54 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2632953840","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632953840?lang=en_us&edition=fundamental","pubTime":"2026-05-04 20:18","pubTimestamp":1777897136,"startTime":"0","endTime":"0","summary":"First Tracks Biotherapeutics, Inc. (TRAX) has an average rating of Buy and mean price target of $39.43, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic rese","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632893486","title":"First Tracks Initiated at Overweight by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2632893486","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632893486?lang=en_us&edition=fundamental","pubTime":"2026-05-04 17:48","pubTimestamp":1777888080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TRAX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 04, 2026 05:48 ET (09:48 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632139939","title":"First Tracks Biotherapeutics initiated with an Overweight at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2632139939","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632139939?lang=en_us&edition=fundamental","pubTime":"2026-05-04 16:40","pubTimestamp":1777884030,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Yasmeen Rahimi initiated coverage of First Tracks Biotherapeutics (TRAX) with an Overweight rating and $54 price target The c...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/first-tracks-biotherapeutics-initiated-with-an-overweight-at-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/first-tracks-biotherapeutics-initiated-with-an-overweight-at-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632162047","title":"Analysts Are Bullish on Top Healthcare Stocks: Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD), First Tracks Biotherapeutics Inc (TRAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2632162047","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632162047?lang=en_us&edition=fundamental","pubTime":"2026-05-02 17:03","pubTimestamp":1777712583,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Resmed Inc CHESS Depositary Interests on a ratio of ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-resmed-inc-chess-depositary-interests-on-a-ratio-of-10-cdis-per-ord-sh-aurmd-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-resmed-inc-chess-depositary-interests-on-a-ratio-of-10-cdis-per-ord-sh-aurmd-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4504","BK4139","LU0170899867.USD","BK4585","RMD.AU","LABU","LU0029874061.USD","BLSX","BK4548","BK4567","LU2177674079.SGD","IE00B5TLWC47.USD","LU0128526141.USD","BK4137","TRAX","BK4082","XBI","BK4588","BK4112","LU2008162690.USD","BLSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630866306","title":"HC Wainwright Initiates First Tracks Biotherapeutics at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2630866306","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630866306?lang=en_us&edition=fundamental","pubTime":"2026-04-28 19:25","pubTimestamp":1777375503,"startTime":"0","endTime":"0","summary":"First Tracks Biotherapeutics (TRAX) has an average rating of buy and mean price target of $37, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630430638","title":"First Tracks Initiated at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2630430638","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630430638?lang=en_us&edition=fundamental","pubTime":"2026-04-28 19:25","pubTimestamp":1777375500,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TRAX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 28, 2026 07:25 ET (11:25 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630371377","title":"First Tracks Biotherapeutics, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating  and Target Price $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2630371377","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630371377?lang=en_us&edition=fundamental","pubTime":"2026-04-28 18:09","pubTimestamp":1777370995,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nAZN4ST4N4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630835389","title":"Weekly Update (WDC, IDT, TRAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2630835389","media":"Smartkarma","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630835389?lang=en_us&edition=fundamental","pubTime":"2026-04-27 01:31","pubTimestamp":1777224686,"startTime":"0","endTime":"0","summary":"utm_source=tiger_community","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.smartkarma.com/home/private-investor-solutions/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4170","BK4588","LU1642822529.SGD","LU0957808578.USD","TRAX","LU1069347547.HKD","GB00BDT5M118.USD","BK4139","WDC","LU0476273544.USD","LU1035773651.USD","BK4115","LU0444973449.USD","LU1815336760.USD","LU1823568750.SGD","LU0081259029.USD","LU0444971666.USD","BK4512","IDT","LU1235294995.USD","LU1046421795.USD","WDCX","LU0006061336.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629847820","title":"First Tracks Initiated at Outperform by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2629847820","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629847820?lang=en_us&edition=fundamental","pubTime":"2026-04-24 21:49","pubTimestamp":1777038540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TRAX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 24, 2026 09:49 ET (13:49 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629452618","title":"First Tracks Biotherapeutics initiated with an Outperform at Leerink","url":"https://stock-news.laohu8.com/highlight/detail?id=2629452618","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629452618?lang=en_us&edition=fundamental","pubTime":"2026-04-24 19:36","pubTimestamp":1777030610,"startTime":"0","endTime":"0","summary":"Leerink analyst David Risinger initiated coverage of First Tracks Biotherapeutics (TRAX) with an Outperform rating and $46 price target. This is an...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/first-tracks-biotherapeutics-initiated-with-an-outperform-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/first-tracks-biotherapeutics-initiated-with-an-outperform-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629845925","title":"Leerink Partners Initiates Coverage on First Tracks Biotherapeutics With Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2629845925","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629845925?lang=en_us&edition=fundamental","pubTime":"2026-04-24 19:33","pubTimestamp":1777030439,"startTime":"0","endTime":"0","summary":"First Tracks Biotherapeutics, Inc. (TRAX) has an average rating of Buy and mean price target of $38.67, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic rese","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629843153","title":"First Tracks Biotherapeutics Inc : Wedbush Assumes Coverage With Outperform Rating; Target Price $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2629843153","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629843153?lang=en_us&edition=fundamental","pubTime":"2026-04-24 19:13","pubTimestamp":1777029234,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nFWN4170UZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629127048","title":"First Tracks Biotherapeutics Inc : Leerink Partners Initiates Coverage With Outperform Rating; Target Price $46","url":"https://stock-news.laohu8.com/highlight/detail?id=2629127048","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629127048?lang=en_us&edition=fundamental","pubTime":"2026-04-24 18:03","pubTimestamp":1777025004,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nFWN4170H6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629786976","title":"First Tracks Biotherapeutics CFO Ajim Tamboli files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2629786976","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629786976?lang=en_us&edition=fundamental","pubTime":"2026-04-24 06:12","pubTimestamp":1776982348,"startTime":"0","endTime":"0","summary":"First Tracks Biotherapeutics filed an initial Form 3 for Chief Financial Officer Ajim Tamboli.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. First Tracks Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 23, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nNDLf57Vm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629737370","title":"First Tracks Biotherapeutics initial beneficial ownership filing shows EcoR1 Capital stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2629737370","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629737370?lang=en_us&edition=fundamental","pubTime":"2026-04-23 05:07","pubTimestamp":1776892059,"startTime":"0","endTime":"0","summary":"EcoR1 Capital filed Form 3 disclosing indirect beneficial ownership of 7,880,094 First Tracks Biotherapeutics common shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. First Tracks Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 22, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDL98DvGG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TRAX","ANAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629092045","title":"Barclays Initiates First Tracks Biotherapeutics at Overweight","url":"https://stock-news.laohu8.com/highlight/detail?id=2629092045","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629092045?lang=en_us&edition=fundamental","pubTime":"2026-04-22 20:03","pubTimestamp":1776859433,"startTime":"0","endTime":"0","summary":"Barclays Initiates First Tracks Biotherapeutics at Overweight","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629801794","title":"First Tracks Biotherapeutics :  Barclays Initiates Coverage With Overweight Rating  and Target Price $40","url":"https://stock-news.laohu8.com/highlight/detail?id=2629801794","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629801794?lang=en_us&edition=fundamental","pubTime":"2026-04-22 18:37","pubTimestamp":1776854239,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nAZN4SS33X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629224054","title":"First Tracks Initiated at Buy by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2629224054","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629224054?lang=en_us&edition=fundamental","pubTime":"2026-04-22 02:58","pubTimestamp":1776797880,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TRAX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 21, 2026 14:58 ET (18:58 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629035857","title":"UBS Initiates Coverage on First Tracks Biotherapeutics With Buy Rating, $45 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2629035857","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629035857?lang=en_us&edition=fundamental","pubTime":"2026-04-21 19:27","pubTimestamp":1776770831,"startTime":"0","endTime":"0","summary":"UBS Initiates Coverage on First Tracks Biotherapeutics With Buy Rating, $45 Price Target","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TRAX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":59,"code":"91000000","status":"200"}]}}